Charles River Laboratories International (CRL) Price to Sales (2009 - 2026)

Charles River Laboratories International has reported Price to Sales for 18 years, with the latest figure at 10.26 in Q2 2026.

• On a quarterly basis, Price to Sales rose 43.39% year-over-year to 10.26 in Q2 2026; TTM through Jun 2026 was 2.57, a 40.53% increase from a year earlier, with the FY2025 full-year figure at 2.5, up 6.19% from the prior year.
• Price to Sales was 10.26 for Q2 2026 at Charles River Laboratories International, up from 7.7 in the prior quarter.
• The five-year high for Price to Sales was 15.51 in Q1 2022, with the low at 7.15 in Q2 2025.
• Average Price to Sales over 5 years is 10.17, with a median of 10.06 recorded in 2025.
• The sharpest annual moves came in 2022 and 2026: Price to Sales plunged 62.64% in 2022, then jumped 43.39% in 2026.
• Over 5 years, Price to Sales stood at 10.09 in 2022, then increased by 18.65% to 11.97 in 2023, then fell by 20.7% to 9.5 in 2024, then rose by 6.17% to 10.08 in 2025, then climbed by 1.72% to 10.26 in 2026.
• The last three Price to Sales figures came in at 10.26 (Q2 2026), 7.7 (Q1 2026), and 10.08 (Q4 2025), per Business Quant data.